Get In Touch
  • According to Transparency Market Research’s latest report on the global diagnostic specialty antibody market for the historical period 2017–2018 and forecast period 2019–2027, advancements in antibody development technology have revolutionized the diagnostic science through which antibodies can be produced against any pathogenic antigen and transformed the diagnostic industry.
  • According to the report, the global diagnostic specialty antibody market was valued at US$ 22.6 Bn in 2018 and is anticipated to expand at a CAGR of 5.3% from 2019 to 2027

To know the scope of our report Get a Sample on Diagnostic Specialty Antibodies Market?

Increase in Reported Cases of Diagnostic Specialty Antibody: A Key Driver

  • Increase in clinical research, evolution of infectious diseases, and unhealthy lifestyle of the population has led to innovation of new biological drugs as well as diagnostic kits. Several biotechnology and biopharmaceutical companies offer different diagnostic assays to meet the unmet medical needs of the health care system, which augment the diagnostic specialty antibody market.
  • In 2014, Epitope Diagnostics, Inc. launched a new set of monoclonal antibody MMAE-ADC and MMAF-ADC ELISA kits, which are specific to detecting monomethyl auristatin E (MMAE) and monomethyl auristatin F (MMAF), the two anti-cancer compounds. Launch of such innovative antibody based diagnostic kits is likely to enable the measurement of the disease condition more accurately. This is likely to increase interest of diagnostic laboratories and hospitals to use these products, which are likely ti augment the growth of diagnostic specialty antibody market
  • Governments of several countries are investing in diagnostic health care. According to the World Bank, global healthcare expenditure was 6% of GDP. In 2016, world health care expenditure was US$ 6.5 Trn. In 2015, health care spending in the U.S. increased by 5.8% to reach US$ 3.2 Trn. The overall share of the U.S. economy devoted to health care spending was 17.8% in 2015, up from 17.4% in 2014. In 2015, total government health care expenditure in Europe was 7.2% of GDP.
  • With respect to government investment in developing antibody-based diagnostic kits, in February 2018, the Bio & Medical Technology Development Program of the National Research Foundation of Korea developed a rapid diagnostic test kit to detect IgG and IgM antibody against Zika virus using monoclonal antibodies and the whole research was funded by the Government of South Korea, likely to drive the diagnostic specialty antibody market.

Get a glimpse of the in-depth analysis through our Report Brochure

Failure of Antibodies in Rapid Diagnostic Test for Routine Diagnosis to Hamper Global Diagnostic Specialty Antibody Market

  • The Ministry of Health and Family Welfare, Government of India, indicated that the use of antibody detecting rapid diagnostic test (ADRDTs) is not the solution to diagnosis of diseases such as malaria, because serelogical testing is not practical for routine diagnosis of an acute parasite infectious disease in terms of the time required for development of antibody. Moreover, in endemic areas of India, the antibody detecting rapid diagnostic test gave false positive test results, as patients suffer due to other reasons. Hence, from March 2018, the Ministry of Health and Family Welfare, prohibited the use of antibody detecting rapid diagnostic tests for routine diagnosis of malaria. Such incidences are projected to hamper the growth of the diagnostic specialty antibody market.

North America to Account for Major Share of Global Diagnostic specialty antibody Market

  • North America leads the global diagnostic specialty antibody market commanding more than 40% share in the global diagnostic specialty antibody market. Recent advances in diagnostic specialty antibody diagnostics, reimbursement for disease screening, and improved access to diagnostics are the major drivers of the diagnostic specialty antibody market in North America.  U.S. is expected to hold major share in the North America diagnostic specialty antibody market during the forecast period, owing to developed health care infrastructure in the region and large patient population along with increasing technological development.
  • Increase in government intervention in the emerging markets has led to rise in awareness about diseases and improvement in the health care infrastructure. Additionally, socioeconomic development has been observed in emerging economies such as Asia, Africa, and Latin America. These factors contribute to the overall increase in spending capacity of the population which likely expect to increase market share of Asia, Africa, and Latin America diagnostic specialty antibody market.
  • Moreover, prevalence of life threatening diseases and infectious diseases such as COVID-19 is high in these regions. According to the WHO estimates, 4.2 million cases were detected till May 13 2020, with nearly 2.9 lakh COVID-19 related deaths. The number of COVID cases is expected to increase across the globe, with 50% of cases in Africa, Asia, and Latin America. Hence, increase in investment in these emerging markets is a major opportunity for key players, and these are anticipated to be major markets for diagnostic specialty antibody infection.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Diagnostic Specialty Antibody Market: Competitive Landscape

  • This report profiles major players in the global diagnostic specialty antibody market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Key players operating in the global diagnostic specialty antibody market include Abcam plc, Sanofi, Abbott laboratories, Hoffmann-La Roche Ltd., Danaher Corporation, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., and Aytu BioScience, Inc.
  • Leading players operating in the global diagnostic specialty antibody market are
    • F. Hoffmann-La Roche Ltd
    • Sanofi
    • Abbott Laboratories.
  • These players offer products with proprietary technologies. Others include
    • Abcam plc
    • Bio-Rad Laboratories, Inc.
    • Boehringer Ingelheim International GmbH
    • Agilent Technologies, Inc.
    • Aytu BioScience, Inc.
    • Aytu Bioscience, Inc.
  • invests in research and developmental activities to develop new and innovative products. It recently acquired and anticipates to commercialize FDA-approved ProstaScint (capromab pendetide), a radiolabeled monoclonal antibody. In January 2016, the company acquired a high-performance analytical flow cytometer platform from Propel Labs. This enables advanced and novice users to perform basic and multi-parameter cytometry for a wide range of applications and chemistries.

Global Diagnostic Specialty Antibody Market: Key Developments

High unmet needs in the global diagnostic specialty antibody market present lucrative opportunities for existing players and new entrants. For instance, Abcam plc plans to strengthen its position in Asia, specifically in China, to increase market share in unpenetrated segments and offer custom products and licensing. Additionally, in November 2016, Roche launched the global cancer immunotherapy Centers of Research Excellence (imCORE) network which brings together world’s leading scientific and clinical experts in cancer immunotherapy to collaborate in investigating promising new treatment approaches. The company announced investment up to CHF 100 Mn (US$ 98 Mn) to support basic and clinical research collaborations related to cancer immunotherapy.

The report on the global diagnostic specialty antibody market discusses individual strategies followed by company profiles of manufacturers of diagnostic specialty antibody treatment products. The competitive landscape section has been included in the diagnostic specialty antibody market report to provide readers with a dashboard view and a company diagnostic specialty antibody market share analysis of key players operating in the global diagnostic specialty antibody market.

TMR’s report on the global diagnostic specialty antibody market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period 2019–2027. The report provides the revenue of the global diagnostic specialty antibody market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) of the global diagnostic specialty antibody market during the forecast period.

 

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global diagnostic specialty antibody market.

 

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global diagnostic specialty antibody market.

 

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global diagnostic specialty antibody market. These indices serve as valuable tools for existing players in the diagnostic specialty antibody market as well as for entities interested in entering the global market.

 

The report delves into the competitive landscape of the global diagnostic specialty antibody market. Key players operating in the global diagnostic specialty antibody market have been identified, and each one of these has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global Diagnostic Specialty Antibody market that have been profiled in this report.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Global Diagnostic Specialty Antibody Market – Segmentation

 

 

 

Antibody Type

End-user

Application

Region

Monoclonal Antibodies

Hospitals

Hepatitis Diagnosis

North America

Polyclonal Antibodies

Diagnostic Laboratories

Tuberculosis Diagnostics

Europe

Recombinant Polyclonal Antibodies

Others

Dengue Diagnostics

Asia Pacific

 

 

Oncology Diagnostics

Latin America

 

 

HIV Diagnostics

Middle East & Africa

 

 

Infectious Disease Diagnostics

 

 

 

Others Diagnostics

 

 

 

Key Questions Answered in Global Diagnostic Specialty Antibody Market Report

 

  • What is the scope of growth of product companies in the global diagnostic specialty antibody market?
  • What will be the Y-o-Y growth of the global diagnostic specialty antibody market between 2019 and 2027?
  • What is the influence of changing trends in antibodies on the global diagnostic specialty antibody market?
  • Will North America continue to be the most profitable market for providers of diagnostic specialty antibody treatment products?
  • Which factors will hamper the growth of the global diagnostic specialty antibody market during the forecast period?
  • Which are the leading companies in the global diagnostic specialty antibody market?

 

 

Research Methodology

A unique research methodology has been utilized by TMR to conduct a comprehensive research on the growth of the global diagnostic specialty antibody market and arrive at conclusions on the growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred by analysts during the production of the global diagnostic specialty antibody market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the global diagnostic specialty antibody market as primary sources.

These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from leaders in the diagnostic specialty antibody market. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global diagnostic specialty antibody market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and two bottom-up approaches to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global diagnostic specialty antibody market more reliably and accurately.

Regional Segmentation of Global Diagnostic Specialty Antibody Market

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The global diagnostic specialty antibodies market has been segmented as follows:

Antibody Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Polyclonal Antibodies

Application

  • Hepatitis Diagnosis
  • Tuberculosis Diagnostics
  • Dengue Diagnostics
  • Oncology Diagnostics
  • HIV Diagnostics
  • Infectious Disease Diagnostics
  • Others

End-user

  • Hospitals
  • Diagnostic Laboratories
  • Others

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Diagnostic Specialty Antibodies Market

Buy Now